# WELLPHARMA

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/wellpharma

- Industry: Consumer Products
- Headquarters: Tokyo, Japan
- Website: www.wellpharma.co.jp
- Total disclosed funding: $1.1M
- Latest round: Series A (May 12, 2022)
- Investors on record: 2

## About

Based in Japan, and founded in 2018, WELLPHARMA, formerly known as Beauty Nutrition Co., Ltd., operates as an original equipment manufacturing (OEM) company. In May 2022, WELLPHARMA Inc. raised JPY 150 million in Series A funding led by POLA OBIS HOLDINGS INC. and MTG Ventures. As of 2022, the company’s CEO is Issei Fukuda.

WELLPHARMA manufactures a wide range of products such as CBD (cannabidiol) oil, supplements, gummies, hard capsules, soft drinks, pet oil, cosmetics, and more. In addition, the company also conducts pharmaceutical research on ligands, which are molecules that firmly bind to particular bodily receptors.

The company plans to use the funds raised in May 2022 to support product launch, commercialization, and development, and to strengthen corporate functions and recruitment.

## Funding rounds

- Series A, May 12, 2022, $1.1M — POLA ORBIS HOLDINGS INC., MTG Ventures

## Investors

- POLA ORBIS HOLDINGS INC. — Series A
- MTG Ventures (https://capitalatlas.ai/funds/mtg-ventures) — Series A